Literature DB >> 15652408

Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat.

John H Gilmore1, L Fredrik Jarskog, Swarooparani Vadlamudi.   

Abstract

Maternal infection during pregnancy is associated with increased risk for neurodevelopmental disorders. Polyriboinosinic-polyribocytidilic acid (poly I:C) or saline was administered to rats to model maternal infection; levels of TNFalpha, brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF) were determined by ELISA. TNFalpha was significantly increased in maternal plasma, placenta, and amniotic fluid, while it was significantly decreased in fetal liver/spleen and neonatal brain. NGF and BDNF were significantly decreased in the placenta and fetal liver/spleen. There was no change in BDNF or NGF in the fetal or neonatal brain. Changes in TNFalpha, BDNF, and NGF after maternal exposure to poly I:C represent a potential mechanism through which maternal infection increases risk for neurodevelopmental disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15652408     DOI: 10.1016/j.jneuroim.2004.10.008

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  66 in total

1.  Murine adult neural progenitor cells alter their proliferative behavior and gene expression after the activation of Toll-like-receptor 3.

Authors:  A Melnik; S Tauber; C Dumrese; O Ullrich; S A Wolf
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

2.  Animal models of gene-environment interactions in schizophrenia.

Authors:  Yavuz Ayhan; Akira Sawa; Christopher A Ross; Mikhail V Pletnikov
Journal:  Behav Brain Res       Date:  2009-04-18       Impact factor: 3.332

Review 3.  A review of the fetal brain cytokine imbalance hypothesis of schizophrenia.

Authors:  Urs Meyer; Joram Feldon; Benjamin K Yee
Journal:  Schizophr Bull       Date:  2008-04-11       Impact factor: 9.306

4.  Differential monocyte responses to TLR ligands in children with autism spectrum disorders.

Authors:  Amanda M Enstrom; Charity E Onore; Judy A Van de Water; Paul Ashwood
Journal:  Brain Behav Immun       Date:  2009-08-08       Impact factor: 7.217

5.  Maternal immune activation produces cerebellar hyperplasia and alterations in motor and social behaviors in male and female mice.

Authors:  Tooka Aavani; Shadna A Rana; Richard Hawkes; Quentin J Pittman
Journal:  Cerebellum       Date:  2015-10       Impact factor: 3.847

6.  The Impact of Maternal High-Fat Diet Consumption on Neural Development and Behavior of Offspring.

Authors:  Elinor L Sullivan; Elizabeth K Nousen; Katherine A Chamlou; Kevin L Grove
Journal:  Int J Obes Suppl       Date:  2012

7.  Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC.

Authors:  Charles V Vorhees; Devon L Graham; Amanda A Braun; Tori L Schaefer; Matthew R Skelton; Neil M Richtand; Michael T Williams
Journal:  Synapse       Date:  2012-05-15       Impact factor: 2.562

8.  Maternal immune activation causes age- and region-specific changes in brain cytokines in offspring throughout development.

Authors:  Paula A Garay; Elaine Y Hsiao; Paul H Patterson; A K McAllister
Journal:  Brain Behav Immun       Date:  2012-07-25       Impact factor: 7.217

9.  Neuroinflammation resulting from covert brain invasion by common viruses - a potential role in local and global neurodegeneration.

Authors:  Jeannine A Majde
Journal:  Med Hypotheses       Date:  2010-03-16       Impact factor: 1.538

10.  Maternal influenza infection during pregnancy impacts postnatal brain development in the rhesus monkey.

Authors:  Sarah J Short; Gabriele R Lubach; Alexander I Karasin; Christopher W Olsen; Martin Styner; Rebecca C Knickmeyer; John H Gilmore; Christopher L Coe
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.